3/6
07:02 pm
crmd
CorMedix (CRMD) had its "outperform" rating reaffirmed by Leerink Partners.
Low
Report
CorMedix (CRMD) had its "outperform" rating reaffirmed by Leerink Partners.
3/6
03:33 pm
crmd
Assessing CorMedix (CRMD) Valuation After Recent Share Price Weakness And Growth Expectations [Yahoo! Finance]
Low
Report
Assessing CorMedix (CRMD) Valuation After Recent Share Price Weakness And Growth Expectations [Yahoo! Finance]
3/6
08:03 am
crmd
CorMedix (CRMD) had its price target lowered by Needham & Company LLC from $15.00 to $14.00. They now have a "buy" rating on the stock.
Low
Report
CorMedix (CRMD) had its price target lowered by Needham & Company LLC from $15.00 to $14.00. They now have a "buy" rating on the stock.
3/5
08:22 pm
crmd
CorMedix Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
CorMedix Q4 Earnings Call Highlights [Yahoo! Finance]
3/5
04:22 pm
crmd
Cormedix Inc (CRMD) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]
Low
Report
Cormedix Inc (CRMD) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]
3/5
03:10 pm
crmd
CorMedix Inc. (CRMD) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
CorMedix Inc. (CRMD) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/5
08:08 am
crmd
CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
3/5
07:30 am
crmd
CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Medium
Report
CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
3/2
08:54 am
crmd
CorMedix Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 5, 2026 [Yahoo! Finance]
Low
Report
CorMedix Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 5, 2026 [Yahoo! Finance]
3/2
08:30 am
crmd
CorMedix Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 5, 2026
Low
Report
CorMedix Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 5, 2026
3/1
05:35 am
crmd
Is It Time To Revisit CorMedix (CRMD) After Its Sharp Year To Date Decline? [Yahoo! Finance]
Low
Report
Is It Time To Revisit CorMedix (CRMD) After Its Sharp Year To Date Decline? [Yahoo! Finance]
2/14
02:42 am
crmd
CorMedix Inc. (CRMD) Analyst/Investor Day Transcript [Seeking Alpha]
Low
Report
CorMedix Inc. (CRMD) Analyst/Investor Day Transcript [Seeking Alpha]
2/12
08:52 am
crmd
CorMedix to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
CorMedix to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/12
08:30 am
crmd
CorMedix to Participate in Upcoming Investor Conferences
Low
Report
CorMedix to Participate in Upcoming Investor Conferences
2/12
06:37 am
crmd
CorMedix (NASDAQ:CRMD) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Low
Report
CorMedix (NASDAQ:CRMD) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
2/11
03:28 pm
crmd
CorMedix Inc. (CRMD) Board Approves Multi-Year $75M Stock Buyback [Yahoo! Finance]
Low
Report
CorMedix Inc. (CRMD) Board Approves Multi-Year $75M Stock Buyback [Yahoo! Finance]
2/11
08:03 am
crmd
CorMedix (NASDAQ:CRMD) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.
Medium
Report
CorMedix (NASDAQ:CRMD) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.
2/2
09:17 am
crmd
CorMedix Therapeutics Announces Share Repurchase Program [Yahoo! Finance]
Medium
Report
CorMedix Therapeutics Announces Share Repurchase Program [Yahoo! Finance]
2/2
08:30 am
crmd
CorMedix Therapeutics Announces Share Repurchase Program
Low
Report
CorMedix Therapeutics Announces Share Repurchase Program
2/1
12:22 am
crmd
Assessing CorMedix (CRMD) Valuation After Recent Share Price Pressure And Long Term Gains [Yahoo! Finance]
Medium
Report
Assessing CorMedix (CRMD) Valuation After Recent Share Price Pressure And Long Term Gains [Yahoo! Finance]
1/31
07:03 pm
crmd
CorMedix Analyst Day To Clarify REZZAYO And DefenCath Phase III Path [Yahoo! Finance]
Medium
Report
CorMedix Analyst Day To Clarify REZZAYO And DefenCath Phase III Path [Yahoo! Finance]
1/31
08:12 am
crmd
H.C. Wainwright Signal Clinical Data to Drive CorMedix Inc. (CRMD) Future Over Commercial Performance [Yahoo! Finance]
Medium
Report
H.C. Wainwright Signal Clinical Data to Drive CorMedix Inc. (CRMD) Future Over Commercial Performance [Yahoo! Finance]
1/29
11:38 am
crmd
CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026 [Yahoo! Finance]
Low
Report
CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026 [Yahoo! Finance]
1/29
08:30 am
crmd
CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026
Medium
Report
CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026
1/23
08:04 am
crmd
CorMedix (NASDAQ:CRMD) had its price target lowered by analysts at HC Wainwright from $18.00 to $13.00. They now have a "buy" rating on the stock.
Low
Report
CorMedix (NASDAQ:CRMD) had its price target lowered by analysts at HC Wainwright from $18.00 to $13.00. They now have a "buy" rating on the stock.